The weight loss injection showing the most promising results in clinical trials is Zepbound (tirzepatide).
Zepbound (Tirzepatide): A New Era in Weight Loss
Zepbound distinguishes itself from other weight loss injections due to its dual mechanism of action.
- It targets both GLP-1 and GIP receptors.
- This dual action may lead to greater weight loss compared to medications that only target GLP-1 receptors.
| Feature | Zepbound (Tirzepatide) | Other Weight Loss Injections (e.g., Semaglutide) |
|---|---|---|
| Receptor Target | GLP-1 and GIP | Primarily GLP-1 |
| Potential Weight Loss | Greater due to dual receptor action | Effective, but potentially less than Zepbound |
| Clinical Trial Results | Showed best results | Demonstrated significant weight loss |
This additional mechanism on GIP receptors is the key factor that potentially gives Zepbound its edge in terms of weight loss efficacy.
